Product NDC: | 0409-3218 |
Proprietary Name: | A-METHAPRED |
Non Proprietary Name: | METHYLPREDNISOLONE SODIUM SUCCINATE |
Active Ingredient(s): | 125 mg/2mL & nbsp; METHYLPREDNISOLONE SODIUM SUCCINATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-3218 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040665 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120221 |
Package NDC: | 0409-3218-15 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-3218-15) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0409-3218-15 |
Proprietary Name | A-METHAPRED |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-3218-15) > 2 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0409-3218 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | METHYLPREDNISOLONE SODIUM SUCCINATE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20120221 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | METHYLPREDNISOLONE SODIUM SUCCINATE |
Strength Number | 125 |
Strength Unit | mg/2mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |